Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)

NCT02365246 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitaire Ziekenhuizen KU Leuven